| Mary Eva Herriman, LPN | |
|
11 East St, Benton, ME 04901-3309 | |
| (207) 238-9923 | |
| Not Available |
| Full Name | Mary Eva Herriman |
|---|---|
| Gender | Female |
| Speciality | Licensed Practical Nurse |
| Location | 11 East St, Benton, Maine |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1326474040 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 164W00000X | Licensed Practical Nurse | LPN12389 (Maine) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mary Eva Herriman, LPN 32 S Garand St, Winslow, ME 04901-7080 Ph: (207) 660-5130 | Mary Eva Herriman, LPN 11 East St, Benton, ME 04901-3309 Ph: (207) 238-9923 |
News Archive
Epizyme, Inc., a company leading the discovery and development of first-in-class, targeted cancer therapeutics against epigenetic targets, announced today the publication of two new review papers in the area of epigenetics. Together, the articles provide an overview of the major epigenetic enzyme classes, as well as chemical biology approaches for discovering small molecule inhibitors of these epigenetic enzymes, and demonstrate Epizyme's scientific leadership in the area of epigenetics.
Roche Diagnostics and CapitalBio have announced their intention to initiate a strategic partnership targeting molecular diagnostic applications and the development of technologies to fill the unmet needs of researchers worldwide. This new development builds on the genomics and diagnostics expertise of the two companies and will focus on furthering microarray technologies and complementary products for molecular diagnostic applications.
Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer.
While COVID-19 vaccines are available to all adults in England, new research suggests a disproportionate number of people who have not gotten the vaccine work in public-facing jobs. In addition, people who work from home were more likely to be vaccinated, suggesting ‘work from policies' are limited in their effectiveness in preventing hospitalizations and COVID-19 deaths.
Herd immunity to Covid-19 could be achieved with less people being infected than previously estimated according to new research.
› Verified 4 days ago